Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Porphyria, Chester : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
ALA Dehydratase Deficiency Porphyria

Diabetic Ketoacidosis

Polyarteritis Nodosa

Porphyria, Acute Intermittent

Porphyria, Hereditary Coproporphyria

Toxicity, Arsenic

Toxicity, Lead

Uremia




Patient Education
Click here for patient education.



Author: Koyamangalath Krishnan, MD, FRCP, FACP, Dishner Endowed Chair of Excellence in Medicine, Professor of Medicine and Chief of Hematology-Oncology, Program Director, Hematology-Oncology Fellowship, James H Quillen College of Medicine at East Tennessee State University

Koyamangalath Krishnan is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, American Society of Clinical Oncology, American Society of Hematology, and Royal College of Physicians

Coauthor(s): Vijay Ramu, MBBS, Staff Physician, Department of Internal Medicine, East Tennessee State University; Harsha Vardhana, MD, Medical Oncology Fellow, Department of Internal Medicine, Division of Hematology/Oncology, James H Quillen College of Medicine at East Tennessee State University

Editors: Clarence Sarkodee-Adoo, MD, Consulting Staff, Department of Bone Marrow Transplantation, City of Hope Samaritan BMT Program; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Marcel E Conrad, MD, BS, (Retired) Distinguished Professor of Medicine, University of South Alabama; Rajalaxmi McKenna, MD, FACP, Consulting Staff, Department of Medicine, Southwest Medical Consultants, SC, Good Samaritan Hospital, Advocate Health Systems; Emmanuel C Besa, MD, Professor, Department of Medicine, Division of Hematologic Malignancies, Kimmel Cancer Center, Thomas Jefferson University

Author and Editor Disclosure

Synonyms and related keywords: Dobson's complaint, heme biosynthesis, enzyme defects, acute intermittent porphyria, AIP, acute porphyria, intermittent acute porphyria, IAP, biochemical defects, variegate porphyria, VP, neurovisceral dysfunction, metabolism error, hypertension, abdominal colic, psychosis, neuropathy, Chester porphyria gene, inborn error of metabolism, porphobilinogen deaminase, protoporphyrinogen oxidase

Background

Porphyrias are inborn errors of metabolism in which specific enzyme defects exist in the heme synthesis pathway. Chester porphyria is a unique type of porphyria with the clinical picture of acute intermittent porphyria (AIP) and the biochemical defects of both acute intermittent porphyria and variegate porphyria (VP). The first description of this disease is from a clinical observation made by an anesthetist, Zorka Bekerus, in Chester, England, in 1963 (hence the name Chester porphyria). The index case, Peter Dobson, was a salmon fisherman born in 1867 in Chester. Numerous family members had the condition, and the family coined the term Dobson's complaint to describe the mysterious illness.

Pathophysiology

Chester porphyria does not conform to any of the recognized types of acute porphyria (see Image 1). The urine porphyrin excretory pattern varies from the pattern of acute intermittent porphyria to variegate porphyria. Chester porphyria exhibits reduction in enzymatic activity of both porphobilinogen deaminase (an enzyme with reduced activity in acute intermittent porphyria) and protoporphyrinogen oxidase (an enzyme with reduced activity in variegate porphyria). Chester porphyria manifests with attacks of neurovisceral dysfunction common to all acute porphyrias. Unlike in variegate porphyrias, cutaneous photosensitivity is not a feature of Chester porphyria.

Frequency

International

Frequency is low, and Chester porphyria is only described in the city of Chester, England.

Mortality/Morbidity

  • Mortality is high. Tracing the ancestry of the Chester family, 14 members had peripheral motor neuropathy; 6 of the 14 members developed bulbar palsy, and 4 died as a result.
  • Morbidity is significant. Many members of the Chester family were afflicted with hypertension and renal disease. Significant morbidity is associated with painful porphyric crises in these patients.

Sex

No sex predilection exists.



History

  • Abdominal pain
  • Constipation and vomiting
  • Headache
  • Seizures
  • Paralysis
  • Psychological disturbance
  • Palpitations
  • High blood pressure

Physical

  • Elevated blood pressure consistent with hypertension
  • Motor neuropathy suggested by flaccid paralysis
  • Evidence of psychosis
    • Delusions
    • Hallucinations
  • Tachyarrhythmias
  • Epilepsy
  • Renal failure
  • Skin manifestations - Not observed

Causes

  • Genetic studies have linked the Chester porphyria gene to chromosome arm 11q.
  • Some of the precipitating factors include the following drugs:
    • Barbiturates
    • Aluminum hydroxide
    • Tricyclic antidepressants
    • Alcohol
  • Other precipitating factors are as follows:
    • Smoking
    • Surgery
    • Metabolic abnormalities such as hyponatremia (also listed as a complication)



ALA Dehydratase Deficiency Porphyria
Diabetic Ketoacidosis
Polyarteritis Nodosa
Porphyria, Acute Intermittent
Porphyria, Hereditary Coproporphyria
Toxicity, Arsenic
Toxicity, Lead
Uremia

Other Problems to be Considered

Diabetic ketoacidosis (with abdominal pain)
Poliomyelitis
Polyneuropathies
Tabes dorsalis (with abdominal pain)
Uremia (with abdominal pain)
Vasculitides (polyarteritis nodosa, lead or arsenic poisoning, Myopathies, hysteria)
Other porphyrias



Lab Studies

  • Urine studies for porphyrins are recommended when an acute attack of porphyria is suspected clinically.
  • Genetic studies can be performed in suspected cases.



Medical Care

  • Currently, no cure exists. The goal of management is to avoid precipitating factors in cases of suspected porphyrias.
  • Treatment is symptomatic.
  • Genetic counseling and understanding the disease and its manifestations may be helpful for family members.

Surgical Care

Patients are at risk of an acute attack of porphyria at the time of surgery. This is because of stress, metabolic abnormalities, and certain drugs used during surgery.



Currently, no cure exists. The goal of management is to avoid precipitating factors in cases of suspected porphyrias. Medically manage symptoms.



Complications

  • Malignant hypertension
  • Renal failure
  • Intracerebral hemorrhage
  • Bulbar palsy
  • Retinal hemorrhage
  • Hyponatremia (also listed as a precipitating factor)
  • Peripheral neuropathy
  • Myopathy
  • Coma and death

Patient Education

  • Genetic counseling and discussion about the disease are essential components of management.



Medical/Legal Pitfalls

  • Failure to diagnose



Media file 1:  This schematic diagram of biochemical abnormality shows the sites of enzymatic defects of the various porphyrias on the left side of the diagram and the dual enzyme abnormality of Chester porphyria (deficiency of porphobilinogen deaminase and protoporphyrinogen oxidase) on the right.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image



  • Bonkowsky HL, Schady W. Neurologic manifestations of acute porphyria. Semin Liver Dis. May 1982;2(2):108-24. [Medline].
  • Church SE. The Chester porphyria. MD Thesis, University of Liverpool. 1986.
  • Crimlisk H. Dobson''s complaint: the story of the chester porphyria. BMJ. Jan 30 1999;318(7179):336A.
  • McColl KE, Thompson GG, Moore MR, et al. Chester porphyria: biochemical studies of a new form of acute porphyria. Lancet. Oct 12 1985;2(8459):796-9. [Medline].
  • Norton B, Lanyon WG, Moore MR, et al. Evidence for involvement of a second genetic locus on chromosome 11q in porphyrin metabolism. Hum Genet. Jul 1993;91(6):576-8. [Medline].
  • Qadiri MR, Church SE, McColl KE, et al. Chester porphyria: a clinical study of a new form of acute porphyria. Br Med J (Clin Res Ed). Feb 15 1986;292(6518):455-9. [Medline].
  • Youngs GR, ed. Dobson's Complaint: The story of the Chester Porphyria. London, England: The Royal College of Physicians of London;1998.

Porphyria, Chester excerpt

Article Last Updated: Dec 19, 2006